ELISA Kit for Baculoviral IAP Repeat Containing Protein 7 (BIRC7)

Format

48T, 96T, 96T×5, 96T×10, 96T×100

Detection range

0.156-10ng/mL

Application

Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species

Homo sapiens (Human)

Sensitivity

The minimum detectable dose of this kit is typically less than 0.059ng/mL

Sample type

Serum, plasma, tissue homogenates, cell lysates and other biological fluids.

Assay length

3h

Method

Double-antibody Sandwich

Test principle

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Baculoviral IAP Repeat Containing Protein 7 (BIRC7). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Baculoviral IAP Repeat Containing Protein 7 (BIRC7). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Baculoviral IAP Repeat Containing Protein 7 (BIRC7), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Baculoviral IAP Repeat Containing Protein 7 (BIRC7) in the samples is then determined by comparing the O.D. of the samples to the standard curve.

Alternative Names

KIAP; LIVIN; ML-IAP; MLIAP; RNF50; Melanoma Inhibitor Of Apoptosis Protein; Kidney Inhibitor Of Apoptosis Protein; Livin Inhibitor-Of-Apoptosis; RING finger protein 50

Item Name

Baculoviral IAP Repeat Containing Protein 7

Research Area

Immune molecule;

Reference

Expression and Clinical Significance of Protein in Hepatocellular Carcinoma;